BIBS: Birth Control to Improve Birth Spacing

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05240066
Collaborator
Boston Medical Center (Other), Harvard Medical School (HMS and HSDM) (Other), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
1,400
2
16.4
700
42.8

Study Details

Study Description

Brief Summary

This study aims to investigate the drivers of postpartum contraceptive use with a prospective cohort. The study will clarify the role of contraceptive knowledge, attitudes, norms, and self-efficacy in driving intention to initiate contraception postpartum and describe the impact of environmental barriers on enacting intended postpartum contraception initiation.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study will be a sequential mixed-methods design with a prospective cohort to identify and explore barriers to contraceptive initiation both immediately after birth and prior to hospital discharge, as well as throughout the fourth trimester. It will include a baseline patient survey, electronic medical record data pull, follow up survey, and qualitative interviews.

    The investigators will enroll 1400 patients into the prospective cohort, selecting individuals enrolled at prenatal care visits at two sites. The baseline survey will be self-administered. The investigators will then contact participants for a follow-up survey at 12 weeks postpartum. Surveys will be self-administered through a link received by text message or email. Additional analyses will draw on retrospectively collected medical record data.

    The investigators will invite a subset of 25-30 study subjects to participate in qualitative interviews.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1400 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Birth Control to Improve Birth Spacing: a Prospective Longitudinal Cohort Study
    Actual Study Start Date :
    Feb 17, 2022
    Anticipated Primary Completion Date :
    Oct 31, 2022
    Anticipated Study Completion Date :
    Jun 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Desired birth spacing [Baseline]

      self-reported desire to space or births

    2. Contraceptive attitudes and norms [Baseline]

      measured via validated psychometric scales; Examining Contraceptive Use and Unmet Need Study, 12-58 range, higher score indicates more knowledge, citation: Callegari, Lisa S., MD, MPH, Zhao, Xinhua, PhD, Schwarz, Eleanor Bimla, MD, MS, Rosenfeld, Elian, PhD, Mor, Maria K., PhD, & Borrero, Sonya, MD, MS. (2017). Racial/ethnic differences in contraceptive preferences, beliefs, and self-efficacy among women veterans. American Journal of Obstetrics and Gynecology, 216(5), 504.e1-504.e10. DOI: 10.1016/j.ajog.2016.12.178

    3. contraceptive self-efficacy [Baseline]

      measured via validated psychometric scales; Examining Contraceptive Use and Unmet Need Study, 12-58 range, higher score indicates more knowledge, citation: Callegari, Lisa S., MD, MPH, Zhao, Xinhua, PhD, Schwarz, Eleanor Bimla, MD, MS, Rosenfeld, Elian, PhD, Mor, Maria K., PhD, & Borrero, Sonya, MD, MS. (2017). Racial/ethnic differences in contraceptive preferences, beliefs, and self-efficacy among women veterans. American Journal of Obstetrics and Gynecology, 216(5), 504.e1-504.e10. DOI: 10.1016/j.ajog.2016.12.178

    4. Contraceptive knowledge [Baseline]

      measured via the Contraceptive Knowledge Assessment (Haynes et al 2017), 0-25 score range, higher scores reflect greater knowledge. Haynes MC, Ryan N, Saleh M, Winkel AF, Ades V. Contraceptive Knowledge Assessment: validity and reliability of a novel contraceptive research tool. Contraception. 2017 Feb;95(2):190-197. doi: 10.1016/j.contraception.2016.09.002. Epub 2016 Sep 9.

    5. Intention to initiate contraception postpartum [Baseline]

      self-reported desire to use contraception within 12 weeks of birth

    6. Planned postpartum contraceptive method [Baseline]

      self-report of selected method

    7. Contraceptive use [12-week follow up]

      Participants will be asked if they have used a contraceptive method since giving birth.

    8. Environmental barriers to contraceptive use [12-week follow up]

      Participants will rate the difficulty in accessing their desired contraceptive method after giving birth and respond to the reasons why it is - or is not - easy to access.

    Secondary Outcome Measures

    1. Intimate partner violence [12-week follow up]

      measured via validated psychometric scales; Abuse Assessment Screen, 5 items, citation: Soeken, K. L., McFarlane, J., Parker, B., & Lominack, M. C. (1998). The Abuse Assessment Screen: A clinical instrument to measure frequency, severity, and perpetrator of abuse against women. In J. C. Campbell (Ed.), Sage series on violence against women. Empowering survivors of abuse: Health care for battered women and their children (pp. 195-203). Thousand Oaks, CA, US: Sage Publications, Inc.

    Other Outcome Measures

    1. Immediate and delayed postpartum method uptake [72 hours postpartum, 12 weeks postpartum]

      contraceptive method prescribed, inserted, injected, or otherwise provided

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age 18 or older

    • Pregnant

    • Attending prenatal care visits at one of the two study sites

    Exclusion Criteria:
    • Under the age of 18

    • Cannot complete a survey in English or Spanish

    • Do not have physical or cognitive ability to complete a survey on a tablet

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brigham and Women's Hospital Boston Massachusetts United States 02115
    2 Boston Medical Center Boston Massachusetts United States 02118

    Sponsors and Collaborators

    • Brigham and Women's Hospital
    • Boston Medical Center
    • Harvard Medical School (HMS and HSDM)
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Elizabeth Janiak, Assistant Professor, Brigham and Women's Hospital
    ClinicalTrials.gov Identifier:
    NCT05240066
    Other Study ID Numbers:
    • 2021P000762
    • R21HD103977
    First Posted:
    Feb 15, 2022
    Last Update Posted:
    Mar 31, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Elizabeth Janiak, Assistant Professor, Brigham and Women's Hospital

    Study Results

    No Results Posted as of Mar 31, 2022